Related references
Note: Only part of the references are listed.Expression of the HCRP1 mRNA in HCC as an independent predictor of disease-free survival after surgical resection
Ming-Wei Lai et al.
HEPATOLOGY RESEARCH (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients
Jing-Houng Wang et al.
EUROPEAN JOURNAL OF CANCER (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Comparable survival in patients with unresectable hepatocellular carcinoma treated by radiofrequency ablation or transarterial chemoembolization
Kenneth S. Chok et al.
ARCHIVES OF SURGERY (2006)
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
Joseph F. Perz et al.
JOURNAL OF HEPATOLOGY (2006)
Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients
Chien-Hung Chen et al.
LIVER INTERNATIONAL (2006)
Systemic therapy of advanced hepatocellular carcinoma: How hopeful should we be?
Andrew X. Zhu
ONCOLOGIST (2006)
Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter
YH Huang et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Metronomic dosing of chemotherapy: Applications in pediatric oncology
Diana Stempak et al.
CANCER INVESTIGATION (2006)
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma:: A case-controlled study
M Biselli et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients
TF Greten et al.
BRITISH JOURNAL OF CANCER (2005)
Hepatocellular carcinoma: Epidemiology risk factors, and screening
M Sherman
SEMINARS IN LIVER DISEASE (2005)
A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma
M Ikeda et al.
CANCER (2005)
Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases
TS Yang et al.
JOURNAL OF GASTROENTEROLOGY (2004)
Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma
CB O'Suilleabhain et al.
BRITISH JOURNAL OF SURGERY (2003)
Estimating the world cancer burden: GLOBOCAN 2000
DM Parkin et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Share Paper
